TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia [1]

Leukemia

Volumn 13, Issue 3, 1999, Pages 481-483

  Avigad, S ^a   Kuperstein, G ^a   Zilberstein, J ^a   Liberzon, E ^a   Stark, B ^a   Gelernter, I ^a   Kodman, Y ^a   Luria, D ^a   Ash, S ^a   Stein, J ^a   Goshen, Y ^a   Yaniv, I ^a   Cohen, I J ^a   Zaizov, R ^a  

^a Schneider's Children Medical Center in Israel   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ASPARAGINASE; CYCLOPHOSPHAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 12P; CHROMOSOME 21Q; DISEASE COURSE; FEMALE; GENE TRANSLOCATION; HUMAN; INFANT; LETTER; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEWBORN; ORAL DRUG ADMINISTRATION; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION;

EID: 0032973390     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401313     Document Type: Letter

References (15)